Susan G. Komen® Commends Bill Introduction; Urges Quick Passage TOPEKA – Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Linda Featherston (D-Overland Park) for introducing legislation that would prohibit the use of step therapy protocols for metastatic cancer patients. Studies have shown that as little as a four-week delay in treatment for metastatic […]

Susan G. Komen® Applauds Bill Introduction, Urges Quick Passage COLUMBIA – Susan G. Komen®, the world’s leading breast cancer organization applauds Senator Tameika Isaac Devine (D-Richland) for joining Representative Sylleste Davis (R-Berkeley) in introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed […]

Susan G. Komen® Applauds Bill Introduction, Urges Quick Passage PROVIDENCE – Susan G. Komen®, the world’s leading breast cancer organization commends Senator Sam Zurier (D-Providence) and Representative Kathleen Fogarty (D-South Kingstown) for introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast […]

Susan G. Komen® Applauds Bill Introduction; Urges Quick Passage TALLAHASSEE – Susan G. Komen®, the world’s leading breast cancer organization, commends Senator Ana Maria Rodriquez (R-Doral) and Representative Marie Woodson (D-Pembroke Pines) for introducing legislation that would eliminate financial barriers for patients requiring clinically appropriate genetic testing, as well as the recommended screenings based on […]

Susan G. Komen® Commends Bill Introductions; Urges Quick Passage INDIANAPOLIS – Susan G. Komen®, the world’s leading breast cancer organization commends Representative Cherrish Pryor (D-Indianapolis) for working with Komen to introduce legislation on two vitally important issues, removing financial barriers to breast imaging and eliminating step therapy drug protocols for metastatic cancer patients. “These bills […]

Susan G. Komen® Commends Bill Introduction; Urges Quick Passage CONCORD – Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative David Nagel (R-Belknap) for introducing legislation that would provide protections for all patients facing step therapy and prohibit the use of step therapy for metastatic cancer patients. Studies have shown that as little […]

Community Event to Support People with Breast Cancer, Raise Funds for Research and Advocacy WEST PALM BEACH – Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the West Palm Beach MORE THAN PINK Walk on Saturday, Jan. 31. This […]

2026 State, Federal Policy Priorities Include Preserving Funding and Access to Health Care and Programs That Save Lives WASHINGTON, DC – The Susan G. Komen® Center for Public Policy announced its 2026 state and federal advocacy priorities, underscoring the urgent need to protect the breast cancer community from impending changes that will drastically change affordability and access to […]

Highest Awards Presented to Four Researchers, Patient Advocate for Improving Care in Clinics and Communities SAN ANTONIO – Susan G. Komen®, the world’s leading breast cancer organization, today recognized five trailblazers in the field of breast cancer, who have furthered our understanding of genetic mutations, treatment response and cancer progression, improved cancer prevention and care […]

HARRISBURG – Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the passage of SB 88, critical breast imaging legislation in Pennsylvania. Diagnostic and supplemental imaging is a necessary form of breast cancer screening for some high-risk individuals and an important step in determining the need for a biopsy […]

Continued Federal Support is Critical to Maintaining Essential Research and Safety-net Programs WASHINGTON D.C. – NOVEMBER 13, 2025 – Susan G. Komen, the world’s leading breast cancer organization acknowledges the legislation signed into law late yesterday reopening the federal government and ending the record long 43-day shutdown. The law funds most federal agencies at current […]

U.S. Food and Drug Administration Guidance Confirms Vaginal Estrogen Therapy Doesn’t Increase Breast Cancer Risk  WASHINGTON, DC – Susan G. Komen®, the world’s leading breast cancer organization, today expressed its support for the removal of a black box warning label on vaginal estrogen therapies that help alleviate dryness and irritation caused by menopause. The label […]